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Abstract
Objective: To determine the sensitivity and specificity of a Computer Aided Diagnosis (CAD) program for scoring chest x-
rays (CXRs) of presumptive tuberculosis (TB) patients compared to Xpert MTB/RIF (Xpert).
Method: Consecutive presumptive TB patients with a cough of any duration were offered digital CXR, and opt out HIV
testing. CXRs were electronically scored as normal (CAD score #60) or abnormal (CAD score.60) using a CAD program. All
patients regardless of CAD score were requested to submit a spot sputum sample for testing with Xpert and a spot and
morning sample for testing with LED Fluorescence Microscopy-(FM).
Results: Of 350 patients with evaluable data, 291 (83.1%) had an abnormal CXR score by CAD. The sensitivity, specificity,
positive predictive value (PPV) and negative predictive value (NPV) of CXR compared to Xpert were 100% (95%CI 96.2–100),
23.2% (95%CI 18.2–28.9), 33.0% (95%CI 27.6–38.7) and 100% (95% 93.9–100), respectively. The area under the receiver
operator curve (AUC) for CAD was 0.71 (95%CI 0.66–0.77). CXR abnormality correlated with smear grade (r = 0.30, p,0.0001)
and with Xpert CT(r = 0.37, p,0.0001).
Conclusions: To our knowledge this is the first time that a CAD program for TB has been successfully tested in a real world
setting. The study shows that the CAD program had high sensitivity but low specificity and PPV. The use of CAD with digital
CXR has the potential to increase the use and availability of chest radiography in screening for TB where trained human
resources are scarce.
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Introduction
Recently there has been renewed interest in the role of chest x-
ray (CXR) in the diagnosis of tuberculosis (TB), especially with
advances that have been made with digital technology [1,2].
Particularly, there has been an increasing interest in developing
computer aided diagnostic systems for detection of TB [3–5]. The
advances in digital technology have made CXR cheaper, easier to
use because films and chemicals are no longer needed and more
reliable because automatic exposure control largely avoids
unreadable images and also makes it possible to score CXRs
digitally using computer aided diagnosis (CAD) [6–8]. In high
burden TB and HIV settings, the use of CXR in TB diagnosis has
been limited by the scarcity of personnel that can interpret CXR
correctly but also by the large work load required to read CXRs
manually [3]. Digital scoring of CXR therefore has the potential to
increase the use of CXR in these settings as it does not have these
limitations.
Studies have shown high variability in human scoring of CXRs
with wide ranges of sensitivity and specificity [9–15]. Furthermore,
inter-reader and intra-reader agreement also vary widely, although
the use of standard classification systems for CXR scoring has
improved agreement [10–12,16–18]. On the other hand, CAD
systems have the potential to reduce inter-reader and intra-reader
variability and also the potential to reduce detection errors
[19,20]. Additionally, CAD is trained on digital CXR images and
performance might vary with the quality of the scanned films.
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The resurgence of TB has seen renewed interest and progress in
new technologies for diagnosis of TB such as the molecular based
tool, the Xpert MTB/RIF (Xpert) [21–23]. Whilst Xpert has been
shown to have high sensitivity and high specificity [24–28], its
extensive use in resource constrained settings is partly limited by its
high cost [23,29]. It has been suggested that extensive use of Xpert
in these settings can be achieved by using Xpert in conjunction
with other screening tests [29]. Chest radiography can be used as a
pre-screening tool for TB with other more sensitive but expensive
tests such as Xpert [9,29]. In this way, the cost of diagnosis can be
minimized through pre-selecting patients so that only those who
are most likely to benefit from an expensive but sensitive tool have
access, thus improving cost effectiveness.
As part of a TB REACH Xpert implementation evaluation
project we conducted a prospective study to evaluate the use of a
CAD program to digitally score CXRs of presumptive TB patients
as a pre-screening test to access Xpert or Fluorescence microscopy
(FM) diagnosis. In this paper, we report the sensitivity and
specificity of a CAD program compared to Xpert and describe the
relationship between CAD score and TB detection by Xpert,
smear microscopy and clinical TB diagnosis. We also describe the
association between patients presenting symptoms and bacillary
load with the degree of CXR abnormality.
Ethics statement
The study had ethical approval from the University of Zambia
Ethics committee. The requirement to obtain individual written
informed consent was waived for presumptive TB patients being
screened as part of the case finding activities, as this was part of
routine health care and all modalities of TB diagnosis included are
currently recommended as best practice.
Methods
Study setting and study population
The study was conducted in a primary health care facility in
Lusaka, Zambia. The health facility is located in peri-urban
Lusaka, and offers services to a population with a high burden for
TB and HIV [30]. The facility notifies over 2,000/100,000
population TB patients yearly, although a low proportion of these
cases are microbiologically confirmed.
The study population comprised individuals from the catch-
ment population of the primary health care facility that presented
to the health facility and met the definition of a presumptive TB
patient. A presumptive TB patient was defined as any patient of
any age who presented with a cough of any duration with or
without other symptoms of TB and was able to submit a sputum
sample. Data presented in this study was collected between June
and July 2013 from consecutive patients presenting during the
study period.
Study design and study procedures
This was a cross sectional prospective study. Enhanced case
finding activities were conducted in the community with the aim of
raising awareness around tuberculosis; symptoms of TB, the link
between TB and HIV, and the importance of seeking care early.
Patients with a cough of any duration were encouraged to visit the
clinic to be assessed for TB. An open access point was established
at the health facility to streamline the diagnostic process. The open
access point allowed patients to present directly to the TB services
without queuing up in the general outpatient clinic before being
investigated for TB, thus bypassing a known barrier to TB
diagnosis of busy overburdened clinics. A presumptive TB patient
register was maintained at the open access point. Patients that
presented to the open access point were registered by allocation of
a presumptive TB patient number; socio-demographic data, and
history of presenting symptoms were collected in line with
requirements for clinical management of presumptive TB patients.
After registration, a CXR request form and HIV counseling and
testing request form with the presumptive TB patient number
were printed only for patients that met the definition of a
presumptive TB patient. Patients that did not meet the definition
of a presumptive TB patient were directed to see a clinician for
assessment and management of their symptoms. Presumptive TB
patients were directed to the CXR unit (Odelca-DR, Delft
Imaging Systems, The Netherlands) located within the same
premises. After the CXR was done, patients were directed to the
HIV counseling and testing unit where opt out HIV testing was
offered in accordance with the current local guidelines for patient
management.
Procedure for automatic scoring of CXR
At the CXR unit, patients were registered by scanning in the
presumptive TB patient number that had been allocated at the
point of registration. The CXRs were scored by a software system
(CAD4TB, version 1.08, Diagnostic Image Analysis Group, The
Netherlands) [4] developed for automatic detection of abnormal-
ities suggestive of pulmonary tuberculosis. The CAD4TB software
had been trained with labeled samples to distinguish between
normal and abnormal CXRs. For this purpose, 945 consecutive
digital CXRs (514 abnormal, 431 normal) acquired at two sites
with a high TB prevalence in Sub-Saharan Africa, located in
Lusaka, Zambia, and Cape Town, South Africa, were used as the
training database. The CAD4TB abnormality score was calculated
by combining the output of two detection systems, a textural
abnormality detection and a shape abnormality detection system.
These detection systems analyze the abnormalities in the
unobscured lung fields which were segmented automatically as
described by van Ginneken et al. [31]. The textural abnormality
system was trained with various descriptive features calculated
from normal and abnormal circular patches in the image to train a
k-nearest neighbor classifier [32] (k-NN) to differentiate between a
normal/abnormal patch in the image. These descriptive features
included moments of intensity distributions of Gaussian derivative
filtered images [33] and the patch position relative to the
segmented lung fields. All patches in the lung fields were classified
using the trained classifier to assign a probability of being
abnormal. A textural abnormality score was calculated by fusing
the probabilistic labels of all the patches. The shape abnormality
detection system was included in the software to handle the CXR
images where the lung fields were not accurately segmented. This
can occur if the CXR contains substantial parenchymal abnor-
malities or large amounts of pleural fluid [34]. Therefore, a shape
model as mentioned in [4] was constructed using lung shapes of
normal CXRs in the training dataset, which was utilized to
compute a shape abnormality score between 0 and 100. A high
shape abnormality score reflects a very abnormal image.
The two abnormality scores computed from the above
described detection systems were used as image descriptive
features to train a k-NN classifier to estimate the combined
abnormality score for a new CXR image. The combined
abnormality score is in the range of 0 to 100, where a higher
score is indicative of more severe abnormalities present on the
CXR image.
Using previously collected CXR data from the same population,
an appropriate threshold for the CAD score was determined. The
area under the receiver operating (ROC) curve on a test set of 969
CXRs (458 normal, 511 abnormal) using a radiological reference
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standard is shown in Figure 1. A threshold of 61 was chosen based
on the shown ROC curve at the operating point where 78%
sensitivity and 77% specificity was achieved. For this study, a CAD
score of 61 and greater was considered abnormal whilst a CAD
score less than or equal to 60 was considered to be normal.
Procedure for sputum testing and TB diagnosis
Xpert MTB/RIF (Cepheid, Inc., Sunnyvale, CA, USA) (Xpert)
instruments and LED fluorescent microscopy (FM) were placed in
the laboratory at the primary health care facility described above.
All patients were requested to submit two spot sputum samples;
one spot sample was tested with Xpert whilst the other was tested
with FM. For FM testing, a further morning sample was also
requested in line with the National TB Program (NTP) guidelines
for testing with sputum smear microscopy. FM and Xpert testing
were done according to the standard operating procedures
[35,36]. Briefly, GeneXpert lysate was added to the sputum
sample using 2X the volume of the sample, the mixture was
incubated for a maximum of 15 minutes with intermittent
vortexing. After the incubation 2 mls of the sample were added
to the Xpert cartridge and loaded into the Xpert instrument
within 30 minutes. Any leftover samples were stored at 4 degrees
for a maximum of 12 hours. Slides were prepared and stained
using Auramine ‘‘O’’ stain at the primary health care facility and
for blinding purposes, the slides were read by a centrally located
team who were not aware of the Xpert results. Smears were
graded positive for: 10 to 19 AFB were seen in 100 microscopic
fields (scored as scanty positive), when 20 to 99 AFB were seen in
100 fields (scored as 1+), when 1 to 10 AFB were seen per field in
at least 50 fields (scored as 2+), and when more than 10 AFB were
seen per field in at 20 fields (scored as 3+). Patients that were not
TB detected by either FM or Xpert underwent a clinical review of
Figure 1. ROC on a test set of 969 CXRs.
doi:10.1371/journal.pone.0093757.g001
Figure 2. Patient flow.
doi:10.1371/journal.pone.0093757.g002
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symptoms, as well as physical examination by a clinician. The
clinician also reviewed the CXR independent of the CAD score to
decide whether or not to commence TB treatment.
Definition of TB diagnosis
A diagnosis of TB in this study was defined as bacteriologically
confirmed TB or clinical TB. Bacteriologically confirmed TB was
defined as Xpert TB detected or FM positive (AFB positive)
whereas clinical TB was defined as TB treatment commenced on
Table 1. Baseline characteristics of presumptive TB patients with abnormal and Normal Chest x-ray.
All Abnormal CXR Normal CXR p-Value
350(%) 291(%) 59(%)
Gender 0.007
Male 215(61.4) 187(64.3) 27(45.8)
Female 135(38.6) 103(35.4) 32(54.2)
Mean age(SD) 36.5(11.6) 36.2(11.4) 37.7(12.4) 0.369
Cough duration 0.912
,2week 93(26.7) 76(26.1) 17(28.8) 0.691
2–8 weeks 226(64.6) 189(64.9) 37(62.7) 0.771
.8 weeks 31(8.9) 26(8.9) 5(8.5) 0.444
Previous TB 0.269
No 272(77.7) 223(76.6) 49(83.0)
Yes 78(22.3) 68(23.4) 10(16.9)
HIV status 0.018
Negative 148(42.3) 115(39.5) 33(55.9)
Positive 190(54.3) 166(57.0) 24(40.7)
Unknown status 12(3.4) 10(3.4) 2(3.4)
Fever 0.053
No 74(21.1) 56(19.2) 18(30.5)
Yes 276(78.9) 235(80.8) 41(69.5)
Weight loss ,0.0001
No 173(49.3) 131(45.0) 42(71.2)
Yes 177(50.7) 160(55.0) 17(28.8)
Chest pains 0.565
No 29(8.3) 23(7.9) 6(10.2)
Yes 321(91.7) 268(92.1) 53(89.8)
Shortness of breath ,0.0001
No 246(70.3) 192(66.0) 54(91.5)
Yes 104(29.7) 99(34.0) 5(8.5)
Night sweats 0.025
No 111(31.7) 85(29.2) 26(44.1)
Yes 239(68.3) 206(70.8) 33(55.9)
Smear result
Negative 298(85.1) 240(82.5) 58(98.3) ,0.0001
Scanty positive 8(2.3) 8(2.7) 0 0.225
1+ 12(3.4) 12(4.1) 0 0.105
2+ 17(4.9) 16(5.5) 1(1.7) 0.160
3+ 15(4.3) 15(5.1) 0 0.059
Xpert Ct
No TB detected 254(72.6) 195(67.0) 59(100.0) ,0.0001
.28(very low TB) 16(4.6) 16(5.5) 0 0.049
22–28(low TB) 20(5.7) 20(6.9) 0 0.022
16–22(medium TB) 36(10.3) 36(12.4) 0 0.001
,16(high TB) 24(6.9) 24(8.2) 0 0.010
doi:10.1371/journal.pone.0093757.t001
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patients without bacteriologically confirmed TB but clinician
decided to commence TB treatment based on symptoms, CXR
and physical examination.
Data Analysis
All data analysis were conducted using STATA Statistical
Software (Stata Corporation Version 11. College Station, TX,
USA). The performance of the CAD system was evaluated using
the area under the receiver operating characteristic (ROC) curve.
The ROC curve with 95% confidence interval was constructed
using bootstrapping [37]. Initially a descriptive data analysis was
done to describe the population that participated in the study.
Patient characteristics were compared between patients with an
abnormal CXR score and those with a normal CXR score.
Significance testing was done using the chi-squared test and the t-
test for categorical and continuous variables, respectively. The
sensitivity, specificity, positive predictive value (PPV) and negative
predictive value (NPV) for the CAD program were determined
against Xpert TB detected. The sensitivity, specificity, PPV and
NPV were initially calculated (with respective 95% confidence
intervals) for the CAD program regardless of smear microscopy
status. Then assuming that only patients with a smear negative
result would proceed to Xpert testing, CAD program performance
was also assessed restricted to patients that were smear negative.
Further the sensitivity and specificity of CAD at different CAD
thresholds was determined. A ROC curve comparing CAD to
Xpert was constructed using Xpert TB as the reference standard.
Further data analysis was performed to determine the correlation
between CAD score and bacillary load using smear grade and
Xpert CT for microscopy and Xpert respectively. To perform this
analysis, Pearson’s correlation coefficient was determined with
respective p-values and 95% confidence intervals. Logistic
regression analysis was performed to determine the association
between selected patient characteristics and symptoms with
abnormal CXR. To perform this analysis, CAD score as the
outcome variable was grouped to form a binary score of #60 and
.60. In univariable analysis, statistical significance was considered
to be a p value of#0.05 and for inclusion in the final multivariable
analysis, only variables with a p value of #0.25 were included.
Results
Among all patients that presented to the open access point
during the study period, 404/458 (88.2%) met the definition of a
Table 2. Sensitivity, specificity of CXR compared to GeneXpert MTB/RIF.
Compared to gold standard-Xpert TB Detected
Sensitivity (%) Specificity% PPV NPV
(95%CI) (95%CI) (95%CI) (95%CI)
CXR regardless of smear status N=350
All* 96/96 (100%) 59/254 (23.2%) 96/291(33.0%) 59/59 (100%)
(96.2–100) (18.2–28.9) (27.6–38.7) (93.9–100)
HIV positive 57/57 (100%) 24/133 (18.0%) 57/166 (34.3%) 24/24 (100%)
(93.7–100) (11.9–25.6) (27.2–42.1) (85.7–100)
HIV negative 35/35 (100%) 33/113 (29.2%) 35/115 (30.4%) 33/33 (100%)
(90.0–100) (21.0–38.5) (22.2–39.7) (89.4–100)
Smear microscopy negative followed by CXR
N=298
All* 45/45 (100%) 58/253 (22.9%) 45/240 (18.7%) 58/58 (100%)
(92.1–100) (17.9–28.6) (14.0–24.3) (93.8–100)
HIV positive 34/34 (100%) 24/133 (18.0%) 34/143 (23.8%) 24/24 (100%)
(89.7–100) (11.9–25.6) (17.1–31.6) (85.7–100)
HIV negative 10/10 (100%) 32/112 (28.6%) 10/90 (11.1%) 32/32 (100%)
(69.1–100) (20.4–37.9) (5.4–19.5) (89.1–100)
*includes Unknown HIV status.
doi:10.1371/journal.pone.0093757.t002
Figure 3. ROC curve comparing CAD score to Xpert TB as the
reference standard.
doi:10.1371/journal.pone.0093757.g003
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presumptive TB patient (figure 2). Amongst these, 13 were aged
less than 15 years and were not included in the analysis. 33
patients did not have a CXR or were unable to provide a sputum
sample for testing, 4 did not have a CAD reading for their CXR
and 4 had an invalid Xpert result giving 350 presumptive TB
patients with full data available (See figure 2). Among these 350
patients 291 (83.1%) had a CXR scored as abnormal (CAD.60)
and the rest were scored as normal (CAD#60). Among 291
patients with abnormal CAD score, Xpert detected TB in 96
(33.0%) and FM detected TB in 52 (17.9%) all of whom were also
detected using Xpert. Among those with normal CXR, Xpert did
not detect any TB, whilst 1 patient was FM positive (1.7%).
There were 215 (61.4%) males and 135 (38.6%) females in the
study population. The mean age of study participants was 36.5
(SD 11.6). The majority of patients had a cough of duration 2–8
weeks; 226 (64.6%). HIV positive individuals made up 54.3% of
the study population. The proportion of patients with an abnormal
CXR was higher among HIV positive patients (p = 0.018), those
with fever (p = 0.053), weight loss (p,0.0001), shortness of breath
(p,0.0001) and night sweats (p = 0.025) (Table 1).
The sensitivity, specificity, PPV and NPV of CAD compared to
Xpert were 100% (95%CI 96.2–100), 23.2% (95%CI 18.2–28.9),
33.0% (95%CI 27.6–38.7) and 100% (95% 93.9–100), respective-
ly. The specificity of CAD among HIV positive individuals was
lower than among negative individuals; 18.0% compared to
29.2% (p= 0.039). If CXRs were only done in those with a
negative smear result, the performance of the CAD program did
not change and was similar to when all individuals were
considered (see Table 2).
Using Xpert as the reference standard, the area under the ROC
curve for CAD was 0.71 (95%CI 0.66–0.77) (See figure 3). The
sensitivity of CAD at different CAD threshold is shown in table 3.
Comparing CAD score and bacillary load, the correlation
coefficient for smear grade compared to CAD score was
r = 0.30(95%CI 0.29–0.31) p,0.0001, and for Xpert CT,
r = 0.37(95%CI 0.36–0.38) p,0.0001.
Patient characteristics associated with abnormal chest x-ray
were male gender adjusted odds ratio (aOR) 2.33(95%CI 1.27–
4.26); HIV positive status aOR 1.89 (95%CI 1.02–3.50); and
reporting the symptom shortness of breath aOR 4.20 (1.55–11.39)
(table 4)
Overall, 97 (27.7%) patients had a confirmed diagnosis of TB by
either FM or Xpert. Among patients without a confirmed
diagnosis, clinical TB diagnosis was made in 71 out of 253
(28.1%) patients (results not shown).
Discussion
To our knowledge this is the first prospective study to report the
use and performance of a computer aided diagnosis system for
detection of TB in a real world setting. In this high HIV
prevalence setting, the CAD program performed well in both HIV
positive and HIV negative patients.
The sensitivity and NPV of CAD was high, and this finding is
similar to what has been shown by other studies that have assessed
CXR performance for diagnosis of TB [9,11,29]. The difference in
this study is that we assessed automatic reading of CXR whereas
other works assessed CXR using human readers. Similarly, the low
specificity observed in this study is similar to findings by Theron et
al. who also found that specificity of CXR alone was below 30%
[29] though this study assessed human scorers.
These findings demonstrate the potential role automatic CXR
scoring has especially where qualified human resources are scarce.
In a previous study performed in the same setting on a similar
population, using the same CAD program, we observed that
Table 3. Sensitivity and specificity at different CAD score thresholds with Xpert TB as the reference standard.
Sensitivity 1-specificity CAD Threshold
0 0 99
0.01 0.00 99
0.02 0.00 97
0.09 0.03 95
0.16 0.08 94
0.18 0.09 93
0.29 0.14 92
0.47 0.23 91
0.59 0.31 88
0.60 0.31 86
0.63 0.32 84
0.75 0.42 82
0.86 0.55 81
0.88 0.55 76
0.88 0.56 74
0.88 0.57 72
0.99 0.75 69
1.00 0.77 61
1.00 0.98 60
1.00 1.00 56
doi:10.1371/journal.pone.0093757.t003
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automatic scoring was similar to that by human readers [20]. The
CAD program used in this study meets the criteria for a good
screening test. Initial screening tests should have a very high
sensitivity so that true positive cases will not be missed. In this
study, the sensitivity of CAD compared to Xpert was 100% and
expectedly the PPV was low. As shown in table 3, a higher
threshold for CAD can be chosen at minimal loss of sensitivity, i.e.
at a threshold of 76, 88% sensitivity and 45% specificity (much
higher than reported in this study) can be achieved. This is
applicable in a setting where a higher throughput is required per
day, for example, where access to Xpert machines is limited.
HIV infection was significantly associated with abnormal CXR
though the specificity of CAD was significantly lower in this group
compared to HIV negative individuals. These findings are
expected because it is known from literature that HIV positive
individuals tend to present with atypical nonspecific CXR changes
which can be due to a myriad number of opportunistic infections
that can mimic TB in clinical presentation [38–41].
Table 4. Univariable and multivariable odds ratios showing patient characteristics associated with abnormal CAD score (61–100).
CAD score $61 N=291(%) Unadjusted OR 95%CI Adjusted OR 95%CI
Gender
Female 103 (35.4) 1.00 1.00
Male 188 (64.6) 2.16 1.23–3.81 2.33 1.27–4.36
Age group
15–24 30 (10.3) 1.00
25–34 112 (38.5) 0.93 0.32–2.69
$35 145 (49.8) 0.73 0.26–2.03
Missing 4 (1.4) -
Cough duration
,2week 76 (26.6) 1.00 -
2–8 weeks 189 (64.9) 1.14 0.61–2.15
.8 weeks 26 (8.9) 1.16 0.39–3.47
Previous TB
No 223 (76.6) 1.00
Yes 68 (24.8) 1.50 0.72–3.10
HIV status
Negative 115 (39.5) 1.00 - 1.00
Positive 166 (57.0) 1.98 1.11–3.53 1.89 1.02–3.50
Unknown status 10
Fever
No 56 (19.2) 1.00 -
Yes 235 (80.8) 1.84 0.98–3.44
Weight loss
No 131 (45.0) 1.00 - 1.00
Yes 160 (55.0) 3.02 1.64–5.55 1.72 0.88–3.36
Chest pains
No 23 (7.9) 1.00 -
Yes 268 (92.1) 1.32 0.51–3.39
Shortness of breath
No 192 (66.0) 1.00 - 1.00
Yes 99 (34.0) 5.57 2.16–14.37 4.20 1.55–11.39
Night sweats
No 85 (29.2) 1.00 -
Yes 206 (70.8) 1.91 1.08–3.39
Number of symptoms
1 3 (1.0) 1.00
2 21 (7.2) 2.10 0.63–12.31
3 43 (14.8) 2.87 0.52–15.77
4 97 (33.30 5.39 1.01–28.84
5 or more 127 (43.6) 9.77 1.79–53.42
doi:10.1371/journal.pone.0093757.t004
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The AUROC for CAD of 0.71 was significantly greater than
0.5 suggesting that the ability by CAD to discriminate between
patients with TB and those without TB was more than a chance
occurrence. CAD seemed able to discern changes synonymous
with TB to a certain degree. CAD’s ability to discern changes
likely due to TB are also observed through the finding that
bacillary load was linearly correlated to the degree of CXR
abnormality though this linear association was weak as indicated
by the finding of correlation coefficients that were between the
values 0.5 and 20.5.
The association between abnormal CXR and some symptoms
of TB suggests that CAD performance could possibly be improved
by adding symptoms. A regression model can be built that takes
into account the CAD score and symptoms to estimate the
likelihood of having TB and this could result in improved
specificity of CAD. Different abnormal CAD score thresholds
could be set depending on individual patients’ clinical presenta-
tion. Validation of these findings is required with larger studies
performed in various settings.
Still 56% among those with highly abnormal CXR did not have
TB detected by Xpert. Patients that were Xpert or FM negative
underwent clinical assessment which included review of CXR and
symptoms as well as physical examination by a clinician to decide
whether or not to start TB treatment. Clinical diagnosis of TB was
made in 28.1% of these cases and several reasons can be advanced
for this finding. Firstly, the CAD system will also score CXR
changes due to pneumonia as highly abnormal. Secondly, it is well
known that the sensitivity of Xpert among smear negative patients
ranges from 60–80% [25,26,28] and in this study, only 15% of the
participants were smear positive. Finally, the sensitivity of Xpert
can be marginally improved when more than one sputum
specimen is examined for each patient [29]. However in this
study only one sample was tested per patient, and this may have
limited the sensitivity of the Xpert test.
The findings in this study suggest that CAD score can be used to
pre-screen patients prior to using Xpert or FM testing. Individuals
with a low CAD score #60 are very unlikely to have TB and
therefore could be offered antibiotics and follow up. In situations
where resources are limited and Xpert is not available to all
patients suspected of having TB then its use could be targeted by
CAD score.
The major limitation of this study was that we used Xpert as the
gold standard for determining the sensitivity and specificity of
CAD as opposed to using mycobacterial culture. However, single
Xpert test has been shown to have a sensitivity of ,98% in smear
positive samples and ,75% in smear negative samples [28,42].
Despite the acknowledged limitation, this study still provides useful
information on the performance of CAD, especially when used in
a high burden setting area where use of such technology is likely to
have the most impact. Further studies are required to validate use
of CAD as well as to ascertain the cost effectiveness of using CAD
to prescreen patients.
Conclusion
The advances that have been made with digital technology have
made it possible to score chest radiographs automatically using
computer aided diagnosis software programs. This prospective
study is the first to demonstrate that CAD has the ability to
discriminate CXR as normal or abnormal and that its ability to
discriminate between patients with TB and those without TB was
more than a chance occurrence. There is potential for roll-out of
digital x-ray technology with CAD programs, especially in high
burden settings where human resources are scarce. In such
situations, CAD and CXR can be used as a pre-screening tool
before applying more expensive diagnostic tests but cost effective-
ness of such strategies would have to be ascertained. These
findings need to be validated with larger studies, using mycobac-
terial culture as a gold standard.
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